摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-(3,5-di-tert-butyl-4-hydroxybenzyl)-N-phenylamine | 32559-14-1

中文名称
——
中文别名
——
英文名称
N-(3,5-di-tert-butyl-4-hydroxybenzyl)-N-phenylamine
英文别名
(3,5-di-tert-butyl-4-hydroxybenzyl)(phenyl)amine;N-(3,5-di-tert-butyl-4-hydroxybenzyl)aniline;2,6-di-tert-butyl-4-((phenylamino)methyl)phenol;N-Phenyl-3.5-di-tert-butyl-4-hydroxybenzylamin;4-(Anilinomethyl)-2,6-di-tert-butylphenol;4-(anilinomethyl)-2,6-ditert-butylphenol
N-(3,5-di-tert-butyl-4-hydroxybenzyl)-N-phenylamine化学式
CAS
32559-14-1
化学式
C21H29NO
mdl
——
分子量
311.467
InChiKey
LIGJHWSYVIBRGG-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    104-105 °C
  • 沸点:
    399.3±37.0 °C(Predicted)
  • 密度:
    1.033±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    6.4
  • 重原子数:
    23
  • 可旋转键数:
    5
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.43
  • 拓扑面积:
    32.3
  • 氢给体数:
    2
  • 氢受体数:
    2

SDS

SDS:10d8bcec925d037421cd50059ab07d3d
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    参考文献:
    名称:
    Inhibitors of lipoprotein(a) assembly
    摘要:
    Compounds of the general structure A and B were investigated for their activity as lipoprotein(a), [Lp(a)], assembly (coupling) inhibitors. SAR around the amino acid derivatives (structure A) gave compound 14-6 as a potent coupling inhibitor. Oral closing of compound 14-6 to Lp(a) transgenic mice and cymologous monkeys resulted in a > 30% decrease in plasma Lp(a) levels after 1-2 weeks of treatment at 100 mg/kg/day.) (C) 2003 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmc.2002.04.001
  • 作为产物:
    参考文献:
    名称:
    Inhibitors of lipoprotein(a) assembly
    摘要:
    Compounds of the general structure A and B were investigated for their activity as lipoprotein(a), [Lp(a)], assembly (coupling) inhibitors. SAR around the amino acid derivatives (structure A) gave compound 14-6 as a potent coupling inhibitor. Oral closing of compound 14-6 to Lp(a) transgenic mice and cymologous monkeys resulted in a > 30% decrease in plasma Lp(a) levels after 1-2 weeks of treatment at 100 mg/kg/day.) (C) 2003 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmc.2002.04.001
点击查看最新优质反应信息

文献信息

  • Metal-free transamidation of benzoylpyrrolidin-2-one and amines under aqueous conditions
    作者:Devaneyan Joseph、Myeong Seong Park、Sunwoo Lee
    DOI:10.1039/d1ob00967b
    日期:——
    in the presence of DTBP and TBAI to afford the transamidated products in good yields. The reactions were conducted under aqueous conditions and good functional group tolerance was achieved. Both aliphatic and aromatic primary amines displayed good activity under metal-free conditions. A radical reaction pathway is proposed.
    N-酰基内酰胺酰胺,如苯甲酰吡咯烷-2-酮、苯甲酰哌啶-2-酮和苯甲酰西泮-2-酮在DTBP和TBAI存在下与胺反应,以良好的收率得到转酰胺基产物。该反应在水性条件下进行,并获得了良好的官能团耐受性。脂肪族和芳香族伯胺在无金属条件下均表现出良好的活性。提出了一种自由基反应途径。
  • Switchable Radical Carbonylation by Philicity Regulation
    作者:Bin Lu、Minghao Xu、Xiaotian Qi、Min Jiang、Wen-Jing Xiao、Jia-Rong Chen
    DOI:10.1021/jacs.2c06677
    日期:2022.8.17
    acyl radical to form the relatively stabilized cyanoalkyl acyl-DMAP salts that engaged in the subsequent substitution with the nucleophilic amines to produce the single carbonylation products. The reaction proceeded smoothly with excellent selectivity in the presence of various amine nucleophiles at room temperature, generating valuable amides and α-ketoamides in a versatile and controlled fashion.
    涉及作为容易获得的 C1 合成子的 CO 的羰基化反应已成为从原料化学品构建羰基化合物的最重要工具之一。尽管有许多通过离子或自由基途径进行羰基化反应的催化方法,但这些方法的一个固有限制是需要控制从相同和简单的起始材料中可转换的单羰基化和双羰基化形成增值产品。在这里,我们描述了一种新策略,该策略利用光氧化还原催化来调节胺偶联配偶体的亲水性,从而驱动可切换的自由基羰基化反应。在双羰基化中,胺首先通过单电子转移氧化转化为氮自由基阳离子并与CO偶联形成氨基甲酰基自由基,其进一步与起始的氰基烷基酰基自由基进行自由基交叉偶联以提供双羰基化产物。在添加化学计量的 4-二甲氨基吡啶 (DMAP) 后,DMAP 竞争性地捕获最初形成的氰基烷基酰基自由基以形成相对稳定的氰基烷基酰基-DMAP 盐,该盐参与随后的亲核胺取代以产生单一羰基化产物。在室温下,在各种胺类亲核试剂存在下,反应以优异的选择性顺利进行,以通用和可控的方式生成有价值的酰胺和
  • ——
    作者:S. V. Bukharov、G. N. Nugumanova、N. A. Mukmeneva
    DOI:10.1023/a:1024910004024
    日期:——
    The acid dissociation of 3,5-di-tert-butyl-4-hydroxybenzyl acetate in the presence of bases or in dimethylformamide favors reaction of this compound with weakly basic nucleophilies.
  • ——
    作者:S. V. Bukharov、V. V. Syakaev、S. N. Pod''yachev、G. N. Nugumanova、N. A. Mukmeneva
    DOI:10.1023/a:1020490525414
    日期:——
    Solvolysis of 3,5-di-tert-butyl-4-hydroxybenzyl acetate in alcohol solutions involves intermediate-formation of 2,6-di-tert-butyl-4-methylene-1-benzoquinone that further takes up a molecule of the alcohol.
  • Inhibitors of lipoprotein(a) assembly
    作者:Karen E Sexton、Helen T Lee、Mark Massa、Janak Padia、William C Patt、Peggy Liao、Jason K Pontrello、Bruce D Roth、Mark A Spahr、Randy Ramharack
    DOI:10.1016/j.bmc.2002.04.001
    日期:2003.11
    Compounds of the general structure A and B were investigated for their activity as lipoprotein(a), [Lp(a)], assembly (coupling) inhibitors. SAR around the amino acid derivatives (structure A) gave compound 14-6 as a potent coupling inhibitor. Oral closing of compound 14-6 to Lp(a) transgenic mice and cymologous monkeys resulted in a > 30% decrease in plasma Lp(a) levels after 1-2 weeks of treatment at 100 mg/kg/day.) (C) 2003 Elsevier Ltd. All rights reserved.
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐